Liver Cancer Therapeutics - Global and China Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Medical Care > Liver Cancer Therapeutics - Global and China Top Players Market Share and Ranking 2025

Liver Cancer Therapeutics - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-06-11
Report Id: 2239374
Industry: Medical Care
Report Page: 95
Chart: 99

PDF Download

Publication Date: 2025-06-11
Report Id: 2239374
Industry: Medical Care
Report Page: 95
Chart: 99

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Liver Cancer Therapeutics Definition
1.2 Global Liver Cancer Therapeutics Market Size and Forecast
1.3 China Liver Cancer Therapeutics Market Size and Forecast
1.4 Share of China Liver Cancer Therapeutics Market with Respect to the Global Market
1.5 Liver Cancer Therapeutics Market Size: China VS Global Growth Rate, 2020-2031
1.6 Liver Cancer Therapeutics Market Dynamics
1.6.1 Liver Cancer Therapeutics Market Drivers
1.6.2 Liver Cancer Therapeutics Market Restraints
1.6.3 Liver Cancer Therapeutics Industry Trends
1.6.4 Liver Cancer Therapeutics Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Liver Cancer Therapeutics, Global Market Share by Company, 2020-2025
2.2 Global Liver Cancer Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Liver Cancer Therapeutics Concentration Ratio
2.4 Global Liver Cancer Therapeutics Mergers & Acquisitions, Expansion Plans
2.5 Global Liver Cancer Therapeutics Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Liver Cancer Therapeutics, China Market Share by Company, 2020-2025
3.2 China Liver Cancer Therapeutics Liver Cancer Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Liver Cancer Therapeutics Industry Chain
4.2 Liver Cancer Therapeutics Upstream Analysis
4.2.1 Liver Cancer Therapeutics Core Raw Materials
4.2.2 Main Manufacturers of Liver Cancer Therapeutics Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Liver Cancer Therapeutics Production Mode
4.6 Liver Cancer Therapeutics Procurement Model
4.7 Liver Cancer Therapeutics Industry Sales Model and Sales Channels
4.7.1 Liver Cancer Therapeutics Sales Model
4.7.2 Liver Cancer Therapeutics Typical Distributors

5 Sights by Type
5.1 Liver Cancer Therapeutics Classification
5.1.1 Targeted Therapy
5.1.2 Radiation Therapy
5.1.3 Immunotherapy
5.1.4 Chemotherapy
5.1.5 Other
5.2 by Type, Global Liver Cancer Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Liver Cancer Therapeutics Consumption Value, 2020-2031

6 Sights by Application
6.1 Liver Cancer Therapeutics Segment by Application
6.1.1 Hepatocellular Carcinoma
6.1.2 Cholangio Carcinoma
6.1.3 Hepatoblastoma
6.1.4 Other
6.2 by Application, Global Liver Cancer Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Liver Cancer Therapeutics Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Liver Cancer Therapeutics Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Liver Cancer Therapeutics Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Liver Cancer Therapeutics Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Liver Cancer Therapeutics Market Size Market Share
7.4 Europe
7.4.1 Europe Liver Cancer Therapeutics Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Liver Cancer Therapeutics Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Liver Cancer Therapeutics Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Liver Cancer Therapeutics Market Size Market Share
7.6 South America
7.6.1 South AmericaLiver Cancer Therapeutics Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Liver Cancer Therapeutics Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Liver Cancer Therapeutics Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Liver Cancer Therapeutics Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Liver Cancer Therapeutics Market Size, 2020-2031
8.3.2 by Type, United States Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Liver Cancer Therapeutics Market Size, 2020-2031
8.4.2 by Type, Europe Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Liver Cancer Therapeutics Market Size, 2020-2031
8.5.2 by Type, China Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Liver Cancer Therapeutics Market Size, 2020-2031
8.6.2 by Type, Japan Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Liver Cancer Therapeutics Market Size, 2020-2031
8.7.2 by Type, South Korea Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Liver Cancer Therapeutics Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Liver Cancer Therapeutics Market Size, 2020-2031
8.9.2 by Type, India Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Liver Cancer Therapeutics Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Liver Cancer Therapeutics Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 ArQule
9.1.1 ArQule Company Information, Head Office, Market Area, and Industry Position
9.1.2 ArQule Company Profile and Main Business
9.1.3 ArQule Liver Cancer Therapeutics Models, Specifications, and Application
9.1.4 ArQule Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.1.5 ArQule Recent Developments
9.2 Bayer
9.2.1 Bayer Company Information, Head Office, Market Area, and Industry Position
9.2.2 Bayer Company Profile and Main Business
9.2.3 Bayer Liver Cancer Therapeutics Models, Specifications, and Application
9.2.4 Bayer Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.2.5 Bayer Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
9.3.2 Bristol-Myers Squibb Company Profile and Main Business
9.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Models, Specifications, and Application
9.3.4 Bristol-Myers Squibb Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.3.5 Bristol-Myers Squibb Recent Developments
9.4 Celsion
9.4.1 Celsion Company Information, Head Office, Market Area, and Industry Position
9.4.2 Celsion Company Profile and Main Business
9.4.3 Celsion Liver Cancer Therapeutics Models, Specifications, and Application
9.4.4 Celsion Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.4.5 Celsion Recent Developments
9.5 Eisai
9.5.1 Eisai Company Information, Head Office, Market Area, and Industry Position
9.5.2 Eisai Company Profile and Main Business
9.5.3 Eisai Liver Cancer Therapeutics Models, Specifications, and Application
9.5.4 Eisai Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.5.5 Eisai Recent Developments
9.6 Exelixis
9.6.1 Exelixis Company Information, Head Office, Market Area, and Industry Position
9.6.2 Exelixis Company Profile and Main Business
9.6.3 Exelixis Liver Cancer Therapeutics Models, Specifications, and Application
9.6.4 Exelixis Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.6.5 Exelixis Recent Developments
9.7 Roche
9.7.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.7.2 Roche Company Profile and Main Business
9.7.3 Roche Liver Cancer Therapeutics Models, Specifications, and Application
9.7.4 Roche Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.7.5 Roche Recent Developments
9.8 Merck
9.8.1 Merck Company Information, Head Office, Market Area, and Industry Position
9.8.2 Merck Company Profile and Main Business
9.8.3 Merck Liver Cancer Therapeutics Models, Specifications, and Application
9.8.4 Merck Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.8.5 Merck Recent Developments
9.9 Pfizer
9.9.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
9.9.2 Pfizer Company Profile and Main Business
9.9.3 Pfizer Liver Cancer Therapeutics Models, Specifications, and Application
9.9.4 Pfizer Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.9.5 Pfizer Recent Developments
9.10 IntegraGen
9.10.1 IntegraGen Company Information, Head Office, Market Area, and Industry Position
9.10.2 IntegraGen Company Profile and Main Business
9.10.3 IntegraGen Liver Cancer Therapeutics Models, Specifications, and Application
9.10.4 IntegraGen Liver Cancer Therapeutics Revenue and Gross Margin, 2020-2025
9.10.5 IntegraGen Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Liver Cancer Therapeutics should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient"s general condition and age.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies and analyses global Liver Cancer Therapeutics status and future trends, to help determine the Liver Cancer Therapeutics market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Liver Cancer Therapeutics, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Liver Cancer Therapeutics market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Liver Cancer Therapeutics by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Liver Cancer Therapeutics by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Liver Cancer Therapeutics key consuming regions, consumption value and demand structure
(5) Liver Cancer Therapeutics industry chains, upstream, midstream and downstream
Market segment by players, this report covers
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen

Market segment by Type, covers
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other

Market segment by Application, can be divided into
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Liver Cancer Therapeutics product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Liver Cancer Therapeutics market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Liver Cancer Therapeutics market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Liver Cancer Therapeutics industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions